Publication - Progress report
New Medicines Reviews 2013
Reports on the role of SMC & Review of IPTR & ADTC
Appendix 1: Medicines approved by SMC April-September 2012
| Drug Name | Publication date | SMC ID | Manufacturer | Status |
|---|---|---|---|---|
| Everolimus (Afinitor) | 06/04/2012 | 777/12 | Novartis Pharmaceuticals UK Ltd | Accepted |
| Insulin detemir (Levemir) | 06/04/2012 | 780/12 | Novo Nordisk | Restricted |
| Etanercept (Enbrel) | 06/04/2012 | 781/12 | Wyeth Pharmaceuticals | Restricted |
| Etanercept (Enbrel) | 06/04/2012 | 782/12 | Wyeth Pharmaceuticals | Restricted |
| Collagenase (Xiapex) | 16/04/2012 | 715/11 | Pifzer | Restricted |
| Pregablin oral solution (Lyrica) | 04/05/2012 | 765/12 | Pfizer | Restricted |
| Alteplase (Actilyse) | 04/05/2012 | 714/11 | Boehringer Ingelheim Ltd | Accepted |
| Tobramycin inhalation powder 28mg (TOBI Podhaler) | 04/05/2012 | 783/12 | Novartis Pharmaceuticals | Accepted |
| Dexmedetomidine hydrochloride (Dexdor) | 04/05/2012 | 784/12 | Orion Pharma | Accepted |
| Exenatide twice-daily in combinaton with insulin (Byetta) | 04/05/2012 | 785/12 | Lilly UK | Accepted |
| Dexamethasone (Ozurdex) 0.7 mg injecton | 04/05/2012 | 652/10 | Allergan | Restricted |
| Fidaxomicin (Dificlir) | 08/06/2012 | 791/12 | Astellas Pharma Ltd | Restricted |
| Eplerenone (Inspra) | 08/06/2012 | 793/12 | Pfizer UK | Accepted |
| Tadalafil (Adcirca) | 08/06/2012 | 710/11 | Eli Lilly & Co. Ltd | Restricted |
| Golimumab (simponi) | 08/06/2012 | 674/11 | MSD/Schering Plough | Restricted |
| Pegylated interferon alfa 2b (Viraferon Peg) | 08/06/2012 | 794/12 | Merck Sharp & Dohme Ltd | Accepted |
| Rufinamide 40mg/mL oral suspension (Inovelon®) | 08/06/2012 | 795/12 | Eisai Ltd | Restricted |
| Abiraterone (Zytiga) | 06/07/2012 | 764/12 | Janssen-Cilag Ltd | Restricted |
| Mercaptopurine (Xaluprine) | 06/07/2012 | 798/12 | Nova Laboratories Limited | Accepted |
| Fingolimod (Gilenya) | 10/08/2012 | 763/12 | Novartis Pharmaceuticals UK Ltd | Restricted |
| Tocilizumab (RoActemra) | 10/08/2012 | 774/12 | Roche | Restricted |
| Colecalciferol (Fultium-D3) | 10/08/2012 | 801/12 | Internis Pharmaceuticals Ltd | Accepted |
| Tegafur/gimeracil/oteracil (Teysuno) | 10/08/2012 | 802/12 | Nordic Pharma Ltd | Restricted |
Contact
Email: VERONICA MOFFAT
There is a problem
Thanks for your feedback